Hypromellose

Hydroxypropyl Methylcellulose (HPMC) Recent Market Dynamics Intelligence, Analysis, and Forecast

I. Market Dynamics Intelligence

1. Price Trends
- Pharmaceutical-grade HPMC: In 2025, the average ex-factory price of mainstream pharmaceutical-grade HPMC (viscosity range: 100–1500 mPa·s, compliant with Chinese Pharmacopoeia 2020 standards) stood at RMB 187,000 per ton, representing a slight year-on-year increase of 1.6%. For premium customized products—such as low-moisture HPMC-LV series and ultra-fine HPMC-UL series—the unit price ranged from RMB 242,000 to RMB 295,000 per ton. Their share of total sales revenue rose from 9.1% in 2023 to 13.7% in 2025.
- Industrial-grade HPMC: According to data from Alibaba.com over the past three months, the price of industrial-grade HPMC ranged from RMB 12.0 to RMB 23.5 per kilogram, varying depending on viscosity, purity, and supplier. For instance, 200,000-viscosity industrial-grade HPMC was priced at approximately RMB 15.0–20.0 per kilogram, whereas high-purity, high-viscosity grades reached up to RMB 468.0 per kilogram.

2. Market Size and Growth
- Global Market: The global hydroxypropyl methylcellulose market is projected to reach USD 2.58 billion by 2030, growing at a compound annual growth rate (CAGR) of 5.5%. In 2025, the global HPMC market generated sales revenue of RMB 18.805 billion, and is forecast to reach RMB 26.479 billion by 2032, reflecting a CAGR of 5.01%.
- Chinese Market: In 2025, China’s pharmaceutical-grade HPMC market size reached RMB 1.863 billion, registering a 12.4% year-on-year growth—3.2 percentage points higher than the overall pharmaceutical excipients industry. China’s total HPMC market size amounted to RMB 5.85 billion in 2025, making it one of the largest consumption markets in the Asia-Pacific region.

3. Supply-Demand Conditions
- Supply Side: As of 2025, seven domestic enterprises possess GMP-certified production capacity for pharmaceutical-grade HPMC. Among them, Shandong Guyu Biotechnology Co., Ltd., Anhui Shanhe Pharmaceutical Excipients Co., Ltd., and Jiangsu Shisheng Chemical Co., Ltd. collectively accounted for 68.5% of the nation’s compliant production capacity. Total industry design capacity stood at 12,800 tons/year, while actual output of pharmaceutical-grade products reached 9,430 tons, yielding a capacity utilization rate of 73.7%.
- Demand Side: Demand for pharmaceutical-grade HPMC continues to grow steadily, primarily driven by deepening generic drug consistency evaluations, upgrading of oral solid dosage forms, widespread adoption of sustained- and controlled-release technologies, and accelerated development of biopharmaceutical formulations. In 2025, approximately 68% of pharmaceutical-grade HPMC demand originated from the oral solid dosage form segment, particularly hydroxypropyl methylcellulose-based sustained-release tablets—whose market share has been rising annually.

4. Import-Export Status
- Import Dependence: China’s self-sufficiency rate for pharmaceutical-grade HPMC reached 82.6% in 2025—up significantly from 63.4% in 2021—largely attributable to domestic manufacturers’ successful technological advancement from industrial-grade to pharmaceutical-grade production capabilities.
- Export Markets: Chinese hydroxypropyl methylcellulose products have gained competitiveness internationally, with certain enterprises exporting to numerous countries and regions worldwide.

II. Analysis and Assessment

1. Price Trend Outlook
- Pharmaceutical-grade HPMC: Prices are expected to maintain stable upward momentum, especially for premium customized products, supported by increasingly stringent quality and performance requirements from downstream customers and enhanced competitiveness of domestic enterprises in high-end segments.
- Industrial-grade HPMC: Prices are highly sensitive to raw material cost fluctuations and competitive dynamics. Going forward, intensifying competition and rising raw material costs may exert upward pressure on industrial-grade HPMC prices.

2. Market Size and Growth Potential
- Pharmaceutical-grade HPMC: With rapid development of the pharmaceutical industry and growing health awareness, the pharmaceutical-grade HPMC market will continue expanding. Notably, policy drivers—including consistency evaluations, quality enhancement of generic drugs, and accelerated commercialization of novel drug delivery systems—will sustain robust demand for high-end pharmaceutical excipients.
- Industrial-grade HPMC: Growth in the industrial-grade HPMC market remains relatively steady but is closely tied to the cyclical performance of end-use industries such as construction and coatings. Urbanization acceleration and ongoing infrastructure investment will provide continued, albeit moderate, growth opportunities.

3. Competitive Landscape
- Pharmaceutical-grade HPMC: The market exhibits relatively concentrated competition, with leading enterprises commanding substantial shares through technological expertise, brand equity, and distribution channel advantages. Increasing regulatory barriers and tightening compliance requirements will further constrain the viability of small- and medium-sized enterprises (SMEs).
- Industrial-grade HPMC: Competition remains fragmented, with numerous SMEs operating across the sector. Intensifying competition coupled with stricter environmental regulations will likely phase out outdated capacities, gradually elevating industry concentration.

III. Forecasts

1. Price Forecast
- Pharmaceutical-grade HPMC: Prices are projected to rise steadily over the coming years, with an average annual growth rate of 5%–10%. Premium customized products may experience even higher growth rates.
- Industrial-grade HPMC: Although subject to multiple influencing factors, industrial-grade HPMC prices are expected to trend upward overall, with an estimated average annual growth rate of 3%–5%.

2. Market Size Forecast
- Global Market: The global hydroxypropyl methylcellulose market will continue expanding, reaching USD 2.58 billion by 2030, growing at a CAGR of 5.5%.
- Chinese Market: China’s HPMC market will sustain rapid expansion, potentially exceeding RMB 10 billion by 2030. Within this, the share attributable to pharmaceutical-grade HPMC is anticipated to further increase.

3. Competitive Landscape Forecast
- Pharmaceutical-grade HPMC: Competition will intensify, with leading players leveraging technological, branding, and distribution advantages to expand their market share. SMEs must prioritize innovation and brand-building to enhance competitiveness.
- Industrial-grade HPMC: Industry consolidation is expected to accelerate; firms possessing scale advantages, technological leadership, and environmental compliance credentials will gain stronger competitive positioning.